PLEYOTROPIC EFFECTS OF METFORMIN

PLEYOTROPIC EFFECTS OF METFORMIN

Metformin, traditionally used for the therapy of diabetes mellitus, possesses a number of diverse pleyotropic effects. The drug, in addition to the glucose-lowering actions, has a beneficial effect on components of the metabolic syndrome, significantly reduces body weight.

Bibliographic Details
Main Author:	L. Ju. Morgunov
Format:	Article
Language:	Russian
Published:	QUASAR, LLC 2015-01-01
Series:	Issledovaniâ i Praktika v Medicine
Subjects:	diabetes mellitus nonalcoholic fatty liver disease cancer obesity
Online Access:	https://www.rpmj.ru/rpmj/article/view/19

Similar Items

RECURRENCE OF BREAST CANCER AFTER SUBCUTANEOUS MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION
by: A. D. Zikiryakhodzhaev, et al.
Published: (2015-01-01)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
by: Georgios Kranidiotis, et al.
Published: (2013-05-01)

Ultrasonographic features associated with diffuse hepatosteatosis among diabetic obese and normal body mass index patients
by: Mahjabeen Liaqat, et al.
Published: (2020-01-01)

Nonalcoholic steatohepatitis in posttransplantation liver: Review article
by: Antônio Ricardo Cardia Ferraz de Andrade, et al.

A look at new therapeutic opportunities in patients with non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2019-12-01)

Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
by: Sneha S. Pillai, et al.
Published: (2020-09-01)

Bariatric surgery and nonalcoholic fatty liver disease: current and potential future treatments
by: Akira eSasaki, et al.
Published: (2014-10-01)

Effect of metformin combined with Liuwei Dihuang pill on serum illness-related molecule contents in T2DM patients with NAFLD
by: Zhong-Ping Zheng, et al.
Published: (2016-05-01)

Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
by: Narendra S. Choudhary, et al.
Published: (2012-07-01)

Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
by: Sarayu A. Pai, et al.
Published: (2019-03-01)

Correlation of Metabolic Indices with Plasma Leptin Level in Patients with Nonalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus and Obesity
by: O.V. Ogneva
Published: (2012-04-01)

A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease
by: Sangeetha Suresh, et al.
Published: (2018-01-01)

Diagnostics of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in Combination with Nonalcoholic Fatty Liver Disease (Literature Review and Own Data)
by: N.O. Кravchun, et al.
Published: (2015-08-01)

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease
by: Marek Waluga, et al.
Published: (2017-09-01)

Hepatobiliary dysfunction in Type-2 diabetes mellitus
by: Piyush Manoria, et al.
Published: (2017-01-01)

Predictors of NAFLD rapidly progression in type 2 diabetes patients
by: G. Mykhalchyshyn
Published: (2020-10-01)

Prevalence and clinical characteristics of NAFLD in chronic liver disease patients from King Abdulaziz University Hospital, Jeddah
by: Hind Ibrahim Fallatah, et al.
Published: (2020-01-01)

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
by: Fatema Abu Bakr Abdel-Moez, et al.
Published: (2019-01-01)

Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
by: Aasim, M., et al.
Published: (2022)

Effect of Probiotic Therapy on Clinical-Biochemical and Instrumental Parameters of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
by: G.P. Mykhalchyshyn, et al.
Published: (2014-05-01)

Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients
by: G. Mykhalchyshyn
Published: (2020-11-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Evaluation of Liver in Type 2 Diabetes Mellitus Using Unenhanced Computed Tomography
by: Huda Osama, et al.
Published: (2020-12-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

The Role of Disturbances of Bioelement Metabolism in Nonalcoholic Fatty Liver Disease in Patients with Diabetes Mellitus Type 2
by: L.V. Zhuravlyova, et al.
Published: (2014-09-01)

Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China
by: W.-J. Zhang, et al.
Published: (2014-02-01)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
by: Khalid Alswat, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease and Type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study
by: Lijun Hu, et al.
Published: (2018-10-01)

The relationship between serum dipeptidyl peptidase-4 enzyme and nonalcoholic fatty liver disease in diabetic and nondiabetic patients
by: Alaaeldin A Dawood, et al.
Published: (2018-01-01)

Influence of Hyperhomocysteinemia Correction on Functional Liver Tests and Lipid Profile in Patients with Nonalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus
by: V.F. Orlovskyi, et al.
Published: (2015-08-01)

Epidemiology and natural history of NAFLD
by: Della Corte Claudia, et al.
Published: (2015-01-01)

Prevalence and Determinants of Hepatic Steatosis in Young Adult Women
by: Xanthakos, Stavra A.
Published: (2006)

Baseline Values of Nonalcoholic Fatty Liver Disease Scores and Its Risk Assessment in Patients with Type 2 Diabetes Mellitus
by: Kalpesh Joshi, et al.
Published: (2021-08-01)

Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice
by: Eunhui Seo, et al.
Published: (2016-02-01)

The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients
by: Yu‐Wen Pan, et al.
Published: (2019-12-01)

Prevalence of Fatty Liver Disease in Obese Children and Adolescents Who Referred to Pediatric Clinic of Kashan University of Medical Sciences, Iran (2012-2013)
by: K Shiasi Arani, et al.
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_8eisgo40ccqnlvbakhfdc3afe1